Trial intelligence / Profile preview

Mechanisms of Statin-Induced Type 2 Diabetes

NCT02437084Phase 4Completed

Sponsor
Stanford University
Start
May 2015
Primary completion
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of atorvastatin in hyperlipidemia, sponsored by Stanford University. Started May 2015; status: completed.

02

Drugs

atorvastatin
03

Conditions

hyperlipidemia

Beyond the preview

Go deeper on NCT02437084.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02437084.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call